Clinical Trial Update: Study to Compare the Effect of Ropinirole Prolonged Release Once-daily Versus Twice-daily [Phase 4]

View source ↗

Summary

A Phase 4 study comparing once-daily ropinirole prolonged-release with a twice-daily regimen in Parkinson's disease has completed and posted results in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Ropinirole prolonged-release (ropinirole)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Parkinson Disease | Phase 4 | Status: COMPLETED | Results posted: 2013-09-09